Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-27

Clinical Trial Update: Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating extended-release Triamcinolone for rotator cuff disease is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamcinolone extended-release (triamcinolone acetonide)

Snippet

Sponsor: Northwell Health | Conditions: Rotator Cuff Tears, Rotator Cuff Tendinitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING